Oxotremorine sesquifumarate

Pricing Availability   Qty
说明: Muscarinic agonist
化学名: 1-[4-(1-Pyrrolidinyl)-2-butynyl]-2-pyrrolidinone sesquifumarate
纯度: ≥98% (HPLC)
说明书
引用文献 (3)
评论
文献 (1)

生物活性 for Oxotremorine sesquifumarate

Oxotremorine sesquifumarate is a muscarinic agonist.

技术数据 for Oxotremorine sesquifumarate

分子量 380.4
公式 C12H18N2O.1.5C4H4O4
储存 Store at RT
纯度 ≥98% (HPLC)
CAS Number 17360-35-9
PubChem ID 6436473
InChI Key WLYYOFJEBGHKEC-VQYXCCSOSA-N
Smiles OC(=O)\C=C\C(O)=O.OC(=O)\C=C\C(O)=O.OC(=O)\C=C\C(O)=O.O=C1CCCN1CC#CCN1CCCC1.O=C1CCCN1CC#CCN1CCCC1

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for Oxotremorine sesquifumarate

溶剂 最高浓度 mg/mL 最高浓度 mM
溶解性
water 9.51 25
DMSO 38.04 100

制备储备液 for Oxotremorine sesquifumarate

以下数据基于产品分子量 380.4。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

选择批次从而根据批次分子量重新计算:
浓度/溶剂体积/质量 1 mg 5 mg 10 mg
1 mM 2.63 mL 13.14 mL 26.29 mL
5 mM 0.53 mL 2.63 mL 5.26 mL
10 mM 0.26 mL 1.31 mL 2.63 mL
50 mM 0.05 mL 0.26 mL 0.53 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

产品说明书 for Oxotremorine sesquifumarate

分析证书/产品说明书
选择另一批次:

参考文献 for Oxotremorine sesquifumarate

参考文献是支持产品生物活性的出版物。

Fisher et al (1984) Differential stimulation in inositol phospholipid turnover in brain by analogs of oxotremorine. J.Neurochem. 43 1171 PMID: 6088696

Moroi-Fetters et al (1988) Muscarinic receptor-mediated phosphoinositide hydrolysis in the rat retina. J.Pharmacol.Exp.Ther. 246 553 PMID: 2841451

Merck Index 12 7085


If you know of a relevant reference for Oxotremorine sesquifumarate, please let us know.

按产品操作查看相关产品

查看全部 Non-selective Muscarinic Agonists

关键词: Oxotremorine sesquifumarate, Oxotremorine sesquifumarate supplier, Muscarinic, agonist, Receptors, Acetylcholine, ACh, Non-selective, Muscarinics, 0843, Tocris Bioscience

3 篇 Oxotremorine sesquifumarate 的引用文献

引用文献是使用了 Tocris 产品的出版物。 Oxotremorine sesquifumarate 的部分引用包括:

Deng et al (2013) Label-free cell phenotypic assessment of the biased agonism and efficacy of agonists at the endogenous muscarinic M3 receptors. J Pharmacol Toxicol Methods 68 323 PMID: 23933114

Bragança et al (2016) Ion Fluxes through KCa2 (SK) and Cav1 (L-type) Channels Contribute to Chronoselectivity of Adenosine A1 Receptor-Mediated Actions in Spontaneously Beating Rat Atria. Front Pharmacol 7 45 PMID: 27014060

Carneiro et al (2014) Activation of P2Y6 receptors increases the voiding frequency in anaesthetized rats by releasing ATP from the bladder urothelium. Br J Pharmacol 171 3404 PMID: 24697602


您是否知道使用了 Tocris Oxotremorine sesquifumarate 的优秀论文? 请告知我们.

Oxotremorine sesquifumarate 的评论

目前没有该产品的评论。 Be the first to review Oxotremorine sesquifumarate and earn rewards!

Have you used Oxotremorine sesquifumarate?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Alzheimer's Disease Poster

Alzheimer's Disease Poster

Alzheimer's disease (AD) is a debilitating and progressive neurodegenerative disease and the most common cause of dementia, affecting approximately 30% of individuals aged over 85 years. This poster summarizes the cellular and molecular mechanisms of AD.